Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,736 | 119,445 | 280,119 | 228,559 | 260,069 |
| Marketable Securities | 730,254 | 778,733 | 677,954 | 387,949 | 411,151 |
| Receivables | 288 | 269 | 403 | 804 | 279 |
| Other current assets | 4,764 | 4,677 | 6,301 | 4,251 | 4,193 |
| TOTAL | $855,793 | $915,787 | $976,242 | $639,259 | $681,276 |
| Non-Current Assets | |||||
| PPE Net | 8,922 | 8,904 | 6,543 | 6,239 | 6,559 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 22,406 | 22,887 | 23,358 | 23,817 | 24,266 |
| TOTAL | $33,628 | $34,091 | $32,201 | $32,356 | $33,125 |
| Total Assets | $889,421 | $949,878 | $1,008,443 | $671,615 | $714,401 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,296 | 8,053 | 8,276 | 6,316 | 7,871 |
| Accrued Expenses | 22,108 | 15,217 | 13,557 | 20,102 | 15,405 |
| Other current liabilities | 15,413 | 16,332 | 396 | N/A | N/A |
| TOTAL | $43,902 | $41,690 | $24,321 | $28,517 | $25,385 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 83 | 166 | 248 | 331 | 414 |
| Other Non-Current Liabilities | 65,882 | 66,218 | 86,314 | 72,010 | 70,487 |
| TOTAL | $65,882 | $66,218 | $86,314 | $72,010 | $70,487 |
| Total Liabilities | $109,784 | $107,908 | $110,635 | $100,527 | $95,872 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 108,898 | 108,659 | 108,280 | 108,044 | 92,695 |
| Common Shares | 109 | 109 | 109 | 92 | 92 |
| Retained earnings | -906,934 | -830,146 | -768,100 | -700,644 | -639,811 |
| Other shareholders' equity | -11,906 | -9,218 | -1,088 | 10 | -64 |
| TOTAL | $779,637 | $841,970 | $897,808 | $571,088 | $618,529 |
| Total Liabilities And Equity | $889,421 | $949,878 | $1,008,443 | $671,615 | $714,401 |